122 related articles for article (PubMed ID: 38290285)
1. Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes.
George DC; Bertrand FE; Sigounas G
Adv Biol Regul; 2024 Jan; 91():101013. PubMed ID: 38290285
[TBL] [Abstract][Full Text] [Related]
2. Notch-1 promotes stemness and epithelial to mesenchymal transition in colorectal cancer.
Fender AW; Nutter JM; Fitzgerald TL; Bertrand FE; Sigounas G
J Cell Biochem; 2015 Nov; 116(11):2517-27. PubMed ID: 25914224
[TBL] [Abstract][Full Text] [Related]
3. MyD88 in DNA repair and cancer cell resistance to genotoxic drugs.
Kfoury A; Le Corf K; El Sabeh R; Journeaux A; Badran B; Hussein N; Lebecque S; Manié S; Renno T; Coste I
J Natl Cancer Inst; 2013 Jul; 105(13):937-46. PubMed ID: 23766530
[TBL] [Abstract][Full Text] [Related]
4. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
Nayak A; Das S; Nayak D; Sethy C; Narayan S; Kundu CN
Cell Oncol (Dordr); 2019 Apr; 42(2):157-171. PubMed ID: 30603978
[TBL] [Abstract][Full Text] [Related]
5. Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway.
Li Y; Wang Z; Jin J; Zhu SX; He GQ; Li SH; Wang J; Cai Y
Biochem Biophys Res Commun; 2020 Mar; 523(4):947-953. PubMed ID: 31964531
[TBL] [Abstract][Full Text] [Related]
6. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
Neradugomma NK; Subramaniam D; Tawfik OW; Goffin V; Kumar TR; Jensen RA; Anant S
Carcinogenesis; 2014 Apr; 35(4):795-806. PubMed ID: 24265293
[TBL] [Abstract][Full Text] [Related]
7. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
[TBL] [Abstract][Full Text] [Related]
8. BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.
Hayakawa Y; Tsuboi M; Asfaha S; Kinoshita H; Niikura R; Konishi M; Hata M; Oya Y; Kim W; Middelhoff M; Hikiba Y; Higashijima N; Ihara S; Ushiku T; Fukayama M; Tailor Y; Hirata Y; Guha C; Yan KS; Koike K; Wang TC
Gastroenterology; 2019 Mar; 156(4):1066-1081.e16. PubMed ID: 30448068
[TBL] [Abstract][Full Text] [Related]
9. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
Meng RD; Shelton CC; Li YM; Qin LX; Notterman D; Paty PB; Schwartz GK
Cancer Res; 2009 Jan; 69(2):573-82. PubMed ID: 19147571
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
12. ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.
Singh S; Arcaroli J; Chen Y; Thompson DC; Messersmith W; Jimeno A; Vasiliou V
PLoS One; 2015; 10(5):e0121648. PubMed ID: 25950950
[TBL] [Abstract][Full Text] [Related]
13. Silencing DVL3 defeats MTX resistance and attenuates stemness via Notch Signaling Pathway in colorectal cancer.
Zhao Q; Zhuang K; Han K; Tang H; Wang Y; Si W; Yang Z
Pathol Res Pract; 2020 Aug; 216(8):152964. PubMed ID: 32414668
[TBL] [Abstract][Full Text] [Related]
14. High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
Negri F; Bozzetti C; Pedrazzi G; Azzoni C; Bottarelli L; Squadrilli A; Lagrasta C; Tamagnini I; Bisagni A; Ragazzi M; Porzio R; Tomasello G; Mori D; Leonardi F; Gnetti L; Crafa P; Sala R; Cascinu S
Oncol Rep; 2019 Dec; 42(6):2750-2758. PubMed ID: 31578584
[TBL] [Abstract][Full Text] [Related]
15. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.
McAuliffe SM; Morgan SL; Wyant GA; Tran LT; Muto KW; Chen YS; Chin KT; Partridge JC; Poole BB; Cheng KH; Daggett J; Cullen K; Kantoff E; Hasselbatt K; Berkowitz J; Muto MG; Berkowitz RS; Aster JC; Matulonis UA; Dinulescu DM
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):E2939-48. PubMed ID: 23019585
[TBL] [Abstract][Full Text] [Related]
16. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
19. Suppression of colon carcinogenesis by targeting Notch signaling.
Miyamoto S; Nakanishi M; Rosenberg DW
Carcinogenesis; 2013 Oct; 34(10):2415-23. PubMed ID: 23729655
[TBL] [Abstract][Full Text] [Related]
20. The Notch pathway in colorectal cancer.
Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
